Skip to main content

Table 2 Remission induction rate and side effects

From: Efficacy and safety of tacrolimus in older adults with ulcerative colitis: a retrospective study

 

Younger

(< 65 yrs. old)

n = 116

Elderly

(≥65 yrs. old)

n = 21

p-value

Patients achieving remission (%)

93 (80.1%)

14 (66.6%)

0.1862

Total adverse effects of TAC:

40

8

0.7507

 *tremor

22

4

0.8426

 *Headache

2

2

0.0981

 *nausea

1

0

0.5632

 *renal impairment

14

4

0.4721

 *hyperglycemia

1

0

0.5632

  1. *Some patients had more than one complication